June 22-25, 2026
San Diego Convention Center
European pharmaceutical company headquartered in Milan, Italy that was formed to develop and commercialize prescription drug products for significant rare/orphan disease indications with its primary focus on providing access to the proprietary first-in-class plant-based prescription drug crofelemer in Europe to address significant rare/orphan gastrointestinal (GI) diseases
Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.